Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Gretchen E. Taylor"'
Autor:
Preston H. Seaberg, Juliana M. Kling, Molly C. Klanderman, Carolyn Mead-Harvey, Kathryn E. Williams, Helene R. Labonte, Atul Jain, Gretchen E. Taylor, Janis E. Blair
Publikováno v:
Medical Education Online, Vol 28, Iss 1 (2023)
ABSTRACTIntroduction Performance on the certifying examinations such as the American Board of Internal Medicine Certification Exam (ABIM-CE) is of great interest to residents and their residency programs. Identification of factors associated with cer
Externí odkaz:
https://doaj.org/article/2818579554f649f18bbcdeea38b20c28
Autor:
Preston H. Seaberg, Juliana M. Kling, Molly C. Klanderman, Carolyn Mead-Harvey, Kathryn E. Williams, Helene R. Labonte, Atul Jain, Gretchen E. Taylor, Janis E. Blair
Publikováno v:
Medical education online. 28(1)
Performance on the certifying examinations such as the American Board of Internal Medicine Certification Exam (ABIM-CE) is of great interest to residents and their residency programs. Identification of factors associated with certification exam resul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::61d80663e0ce13270ced4f9c5907a634
https://pubmed.ncbi.nlm.nih.gov/36443907
https://pubmed.ncbi.nlm.nih.gov/36443907
Autor:
Antonio Jimeno, Ross C. Donehower, Runyan Jin, Ping He, Wells A. Messersmith, Gretchen E. Taylor, W. Thomas Purcell, Arvind Dasari, Rosalind Walker, Daniel A. Laheru, Manuel Hidalgo, Michelle A. Rudek
Publikováno v:
Journal of Clinical Pharmacology
ABT‐751 is an orally bioavailable sulfonamide with antimitotic properties. A nonrandomized phase 1 dose‐escalation study of ABT‐751 in combination with CAPIRI (capecitabine and irinotecan) and bevacizumab was conducted to define the maximum tol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::893a48aace6b63de25fab9bf29e49675
https://doi.org/10.1002/jcph.681
https://doi.org/10.1002/jcph.681
Autor:
N. V. Rajeshkumar, Elizabeth De Oliveira, Ignacio Garrido-Laguna, Anirban Maitra, Maria C. Villaroel, Gretchen E. Taylor, Collins Karikari, Daniel A. Laheru, Ana Salomon, Belen Rubio-Viqueira, Aik Choon Tan, Antonio Jimeno, Ralph H. Hruban, Maria Uson, Manuel Hidalgo, Rajni Sharma
Publikováno v:
Clinical Cancer Research. 17:5793-5800
Purpose: The goal of this study was to evaluate prospectively the engraftment rate, factors influencing engraftment, and predictability of clinical outcome of low-passage xenografts from patients with resectable pancreatic ductal adenocarcinoma (PDA)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::107b052c97cac323ca11e98a3bf71d6f
https://doi.org/10.1158/1078-0432.ccr-11-0341
https://doi.org/10.1158/1078-0432.ccr-11-0341
Autor:
Sarah E. Hoffe, Jason B. Klapman, Hongyan Cai, Christopher L. Wolfgang, Joseph M. Herman, Raj J. Shah, Marcia I. Canto, Kenneth J. Chang, Hao Wang, Ross C. Donehower, Dionne T. Savage, Tony R. Reid, Timothy M. Pawlik, Phuoc T. Tran, Aaron T. Wild, Gretchen E. Taylor, Mark A. Ziegler, Alexander S. Rosemurgy, Daniel A. Laheru
Purpose TNFerade biologic is a novel means of delivering tumor necrosis factor alpha to tumor cells by gene transfer. We herein report final results of the largest randomized phase III trial performed to date among patients with locally advanced panc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9dd55e018b915a8d17bcf96fb596eaa5
https://europepmc.org/articles/PMC4820756/
https://europepmc.org/articles/PMC4820756/
Publikováno v:
Journal of Clinical Oncology. 34:710-710
710 Background: Leptomeningeal metastasis (LM) has been described as a rare form of metastatic disease progression in colorectal cancer (CRC). There remains a paucity of literature with regards to the course and management of LM in CRC. The aim of th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2204e27eeaa04aa9c4fbb21a8c65e2a9
https://doi.org/10.1200/jco.2016.34.4_suppl.710
https://doi.org/10.1200/jco.2016.34.4_suppl.710
Autor:
Ming Zhao, Antonio Jimeno, Preeti Shah, Michelle A. Rudek, Howard Goldsweig, Daniel A. Laheru, Gretchen E. Taylor, Florencia McAllister, N. V. Rajeshkumar, Sheila Linden, Dongweon Song, Ross C. Donehower, Dung T. Le, Manuel Hidalgo
Purpose S-trans,trans-Farnesylthiosalicylic Acid (FTS, salirasib) inhibits Ras-dependent cell growth by dislodging all isoforms of Ras, including mutant Ras, from the plasma membrane. This study evaluated the activity, safety, and toxicity of saliras
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff8eb183a5d4fb869d54a8f122246e61
https://europepmc.org/articles/PMC3557459/
https://europepmc.org/articles/PMC3557459/
Autor:
Michelle A. Rudek, Dung T. Le, Daniel A. Laheru, M. Angenendt, N. V. Rajeshkumar, Sheila Linden, Gretchen E. Taylor, Manuel Hidalgo, Ross C. Donehower, H. Goldsweig, Antonio Jimeno
Publikováno v:
Journal of Clinical Oncology. 27:4529-4529
4529 Background: The Ras signaling pathway stands as a strategic target in pancreatic cancer. S-trans,trans-farnesylthiosalicyclic acid (FTS) inhibits Ras dependent cell growth by dislodging all of the isoforms of Ras from membrane binding sites. Her
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f5470087ee05159919876904dbcd2c62
https://doi.org/10.1200/jco.2009.27.15_suppl.4529
https://doi.org/10.1200/jco.2009.27.15_suppl.4529